James Oliviero
Algemeen Directeur bij CHECKPOINT THERAPEUTICS, INC.
Vermogen: 3 M $ op 30-04-2024
Actieve functies van James Oliviero
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-10-2018 | - |
| Algemeen Directeur | 13-10-2015 | - | |
| President | 13-10-2015 | - | |
| NUVECTIS PHARMA, INC. | Directeur/Bestuurslid | 01-07-2021 | - |
| Independent Dir/Board Member | 01-07-2021 | - |
Loopbaan van James Oliviero
Eerdere bekende functies van James Oliviero
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KERYX BIOPHARMACEUTICALS | Comptroller/Controller/Auditor | 01-05-2003 | 17-04-2015 |
| Financieel Directeur/CFO | 01-04-2009 | 01-09-2015 | |
| Bedrijfssecretaris | 01-05-2003 | 17-04-2015 | |
| Treasurer | 01-05-2003 | 01-09-2015 | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Financieel Directeur/CFO | 01-08-1999 | 01-05-2003 |
Opleiding van James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| NUVECTIS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
- Beurs
- Insiders
- James Oliviero
- Ervaring
